10 November 2022
10 November 2022
For every argument that construes AI as essential, promising and transforming across nearly all industries, there are voiced concerns about this technology. Many people do not trust AI, claiming that intelligent machines will one day dominate humankind. But while this is a remote possibility, the harm that can be done to people (albeit mostly unintentionally) by deep learning algorithms is very tangible – and has already been known to occur in the real world.
03 Nov. 2022
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for 2 Rodent Research Technicians to join our team.
04 November 2022
After receiving her bachelor's degree in Biochemistry and a master's degree in Health Sciences from the University of Minho, which introduced her to the field of immunology, Cardoso embarked upon a PhD in the laboratory of Henrique Veiga-Fernandes at the Champalimaud Foundation to study the role of neuro-immune interactions in metabolism.
03 November 2022
Everything around a malignant tumour and its metastases, from its so-called microenvironment to the patients themselves as individuals, influences cancerous growth, and ultimately the outcome of the disease. This is the take-away message from CRSy2022 – the three-day international scientific symposium that took place at the Champalimaud Foundation, in Lisbon, from 19 to 21 October.
06 October 2022
This public event, organised by the RAISE (Researchers in Action for Inclusion in Science and Education) consortium composed of the NGO Native Scientist, the Champalimaud Foundation and the Instituto de Medicina Molecular João Lobo Antunes (iMM), joined the 49 ERNs that took place in 25 European countries on the same date.